SCIENTIFIC ADVISORS IN PHARMACOECONOMICS AND HEALTH ECONOMICS IN BRAZIL
We have 15 years of experience within Brazilian healthcare and pharmaceutical market, focused on health economics analysis, pharmacoeconomics, and development of market access and pricing strategies.
Our industry knowledge enable us to explain the nuances of reimbursement systems in Brazil. Our economic and statistical skills, and our familiarity with key health care datasets can help you answer fundamental questions about your product in the market, including:
- How big is the market for your product?
- What treatment options are currently being offered to patients in this market?
- How frequently are those options selected?
- What are the costs associated with those treatment options?
- Who are the major competitors in the market?
- Is there a niche for your brand and products?
- What is the best trial endpoint in communicating value to regulatory agencies?
- What is the optimal price in Brazilian market for your product?
- What are the acess barriers for your product?
- KOL: Who are key opinion leaders for your product? Medical Science Liaison...
Our main clients are global pharmaceutical companies, ministries of health, world's largest consulting firms in market intelligence and pharmacoeconomics. They are from Brazil, United States of America, England, Germany, Portugal, and Mexico.
We working with our clients, not for them.
For more information about Marcia Godoy, see Who's Who in the World.
